A neurodegenerative perspective on mitochondrial optic neuropathies
Open accessThe DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Mitochondrial optic neuropathies constitute an important cause of chronic visual morbidity and registrable blindness in both the paediatric and adult population. It is a genetically heterogeneous group of disorders caused by both mitochondrial DNA (mtDNA) mutations and a growing list of nuclear genetic defects that invariably affect a critical component of the mitochondrial machinery. The two classical paradigms are Leber hereditary optic neuropathy (LHON), which is a primary mtDNA disorder, and autosomal dominant optic atrophy (DOA) secondary to pathogenic mutations within the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein. The defining neuropathological feature is the preferential loss of retinal ganglion cells (RGCs) within the inner retina but, rather strikingly, the smaller calibre RGCs that constitute the papillomacular bundle are particularly vulnerable, whereas melanopsin-containing RGCs are relatively spared. Although the majority of patients with LHON and DOA will present with isolated optic nerve involvement, some individuals will also develop additional neurological complications pointing towards a greater vulnerability of the central nervous system (CNS) in susceptible mutation carriers. These so-called "plus" phenotypes are mechanistically important as they put the loss of RGCs within the broader perspective of neuronal loss and mitochondrial dysfunction, highlighting common pathways that could be modulated to halt progressive neurodegeneration in other related CNS disorders. The management of patients with mitochondrial optic neuropathies still remains largely supportive, but the development of effective disease-modifying treatments is now within tantalising reach helped by major advances in drug discovery and delivery, and targeted genetic manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 LHON-MS overlap syndrome. T2 MRI images from a 27-year-old woman with episodes of recurrent optic neuritis over a 10-year period associated with partial visual recovery. There are disseminated high-signal changes within the white matter regions of the brain and cervical spinal cord that are consistent with demyelination [105]](https://figures.cochat.ai/paper-figures/21040ea5b7d6449ab0f37b733fbc8126/a-neurodegenerative-perspective-on-mitochondrial-optic-neuropathies-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The m.11778G>A mutation is the most common LHON mutation, accounting for about 70% of LHON in North America and Europe.1,3,4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 90% of all LHON cases are caused by one of three point mutations in the mtDNA: m.3460G>A in MT-ND1, m.11778G>A in MT-ND4 and m.14484T>C in MT-ND6.4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440 · cited 1×
“11778G>A LHON mutation was the first mtDNA variant linked with human disease and despite three decades of intensive research, there are still several unsolved mysteries, in particular the marked incomplete penetrance and the sex bias associated with this mitochondrial disorder [134].”
BackgroundThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179 · cited 13×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialMutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446 · cited 1×
“1 3 encodes for a mitochondrial inner membrane protein with multifunctional properties [4, 47].”
BackgroundAlexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Self-citationPrevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936 · cited 1×
“Mitochondrial diseases affect at least 1 in 4300 of the population and patients can present with either isolated or multisystemic organ involvement [58].”
BackgroundSelf-citationMitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839 · cited 4×
“14459G>A) in isolated families from Holland, Australia and North America have previously been linked with particularly severe LHON “plus” phenotypes complicated by spastic dystonia, ataxia, juvenile-onset encephalopathy, and psychiatric disturbances [35, 143].”
BackgroundInfluentialSelf-citationA Lethal Defect of Mitochondrial and Peroxisomal Fission
Waterham, H. R., Koster, J., van Roermund, C. W. T., Mooyer, P. A. W., Wanders, R. J. A., & Leonard, J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064436 · Cited by 749 · cited 1×
“Interestingly, DRP1 is also a pro-fission cytosolic protein that is recruited to the mitochondrial outer membrane, and both SPG7 and AFG3L2 encode for mitochondrial AAA proteases that operate as oligomeric complexes to regulate the post-translational processing of OPA1 [39, 78, 135].”
BackgroundRoemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716 · cited 1×
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultDisturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660 · cited 16×
“Rather strikingly, with the exception of WFS1, which encodes for an endoplasmic reticulum protein, all proteins associated with DOA are closely involved in regulating mitochondrial dynamics, pointing towards a key biological pathway essential for RGC maintenance and survival (Table 1) [28, 110].”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- Sadun AAKY, Wurdeman AE, Dao J, Heller K, Sherman J (1994) Morphological findings in the visual system in a case of Leber’s hereditary optic neuropathy. Clin Neurosci 2:165–172
Cited by
Items 101–181 of 181
Wang, H., Ruan, G., Yang, S., Li, H., Sun, Z., Tian, B., Yan, P., Li, Y., Yang, H. S., Zhong, Y., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63361 · Cited by 10
“Genetic examination shows a lack of pathogenic variants related to CSNB. RGCs are of relatively high metabolic requirements (Yu-Wai-Man et al., 2016).”
BackgroundKaštelan, S., Antunica, A. G., Konjevoda, S., Tomić, Z., Sarić, A., Kulaš, M., Kulaš, L., Begović, E. K., Čanović, S., Kovačević, P., et al. (2026) · Biomolecules · doi:10.3390/biom16030445 · Cited by 9
“The RPE exhibits a unique susceptibility to lipid oxidation and defective mitophagy [13,18,28,29].”
InfluentialCastillo, L., Berrozpe‐Villabona, C., García, S. M., Haulani, H., Gómez‐Gutiérrez, C., García, R. S. D., González‐Martínez, A., Fernández‐Sanz, G., Morilla‐Grasa, A., García, V., et al. (2022) · Acta Ophthalmologica · doi:10.1111/aos.15169 · Cited by 9
Hereditary Optic Neuropathies: Induced Pluripotent Stem Cell-Based 2D/3D Approaches
García‐López, M., Arenas, J., & Gallardo, M. E. (2021) · Genes · doi:10.3390/genes12010112 · Cited by 9
“This is caused by either mtDNA mutations that disrupt some electron transport chain (ETC) complex or mutations in nuclear genes coding essential proteins involved in the maintenance of the mitochondrial network [60].”
BackgroundClinical trials in mitochondrial diseases
Karaa, A., & Klopstock, T. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-821751-1.00002-6 · Cited by 8
Skorczyk‐Werner, A., Tońska, K., Maciejczuk, A., Nowomiejska, K., Korwin, M., Ołdak, M., Wawrocka, A., & Krawczynski, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417496 · Cited by 8
“[3,4].”
Moster, M. L., Sergott, R. C., Newman, N. J., Yu-Wai-Man, P., Carelli, V., Bryan, M. S., Smits, G., Biousse, V., Vignal-Clermont, C., Klopstock, T., et al. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001316 · Cited by 7
“L eber hereditary optic neuropathy (LHON) is a maternally inherited blinding bilateral optic neuropathy caused by mitochondrial DNA (mtDNA) missense point mutations affecting complex I in the mitochondrial respiratory chain (1,2), resulting in selective dysfunction and subsequent apoptotic loss of retinal ganglion cel…”
Self-citationZhang, K., Zhang, W., Zhang, L., Hou, X., Tian, R., Hu, Z., Yin, L., & Hu, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06471-w · Cited by 7
Liu, X., Shen, M.-X., Chen, C., Huang, S.-H., Zhuang, X.-R., Ma, Q.-K., Chen, Q., Lu, F., & Yuan, Y.-M. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.05.11 · Cited by 7
Maculopapillary Bundle Degeneration in Optic Neuropathies
Lambiri, D. W., & Levin, L. A. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01343-0 · Cited by 7
“For example, LHON and DOA are both associated with the existence of specific pathogenic mutations in genes encoding mitochondrial proteins [34].”
d’Almeida, O. C., Violante, I. R., Quendera, B., & Castelo-Branco, M. S. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-4153-z · Cited by 7
Muñoz-Úbeda, M., Semenzato, M., Franco‐Romero, A., Junquera, E., Aicart, E., Scorrano, L., & López‐Montero, I. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01167-x · Cited by 6
“Additional work is required to explore (a) the simultaneous transfection of multiple plasmids coding for different Opa1 isoforms and (b) the local administration of lipoplexes within eye, as this organ has been shown to be an excellent target for mitochondrial optic neuropathies gene therapy [69, 70].”
BackgroundXu, X., Zhou, H., Sun, M., Li, Y., Chen, B., Chen, X., Xu, Q., Yu‐Wai‐Man, P., & Wei, S. (2024) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-324628 · Cited by 6
Self-citationSantarelli, R., Morgia, C. L., Valentino, M. L., Barboni, P., Monteleone, A., Scimemi, P., & Carelli, V. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00501 · Cited by 6
Self-citationCharif, M., Chevrollier, A., Guéguen, N., Kane, M. S., Bris, C., Goudenège, D., Desquiret‐Dumas, V., Meunier, I., Mochel, F., Jeanjean, L., et al. (2022) · Genes · doi:10.3390/genes13071202 · Cited by 5
Ezan, P., Hardy, E., Bemelmans, A., Taiel, M., Dossi, E., & Rouach, N. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106681 · Cited by 5
Mutation profile of neurodegenerative mitochondriopathy – LHON in Southern India
Poigaialwar, G., Sathish, P., Shanmugam, M., & Sundaresan, P. (2022) · Gene · doi:10.1016/j.gene.2022.146202 · Cited by 5
Liutkevičienė, R., Sidaraitė, A., Kuliaviene, L., Glebauskienė, B., Jurkutė, N., Aluzaite-Baranauskiene, L., Gelžinis, A., & Žemaitienė, R. (2021) · Medicina · doi:10.3390/medicina57030202 · Cited by 5
“Indeed, LHON is complex disease with multifactorial genetic and environmental triggers interacting with the LHON mtDNA mutation [6].”
BackgroundStudy design and baseline characteristics for the reflect gene therapy trial ofm.11778g>A/ND4-LHON
Subramanian, P. S., Newman, N. J., Moster, M. L., Wang, A.-G., Yu‐Wai‐Man, P., Donahue, S. P., Leroy, B. P., Carelli, V., Biousse, V., Vignal‐Clermont, C., et al. (2022) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2022-001158 · Cited by 4
Self-citationMauring, L., Puusepp, S., Parik, M., Roomets, E., Teek, R., Reimand, T., Pajusalu, S., Kaljurand, K., & Õunap, K. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104821 · Cited by 4
Abnormal large-scale structural rich club organization in Leber's hereditary optic neuropathy
Zhang, J., Wang, L., Ding, H., Fan, K., Tian, Q., Liang, M., Sun, Z., Shi, D., & Qin, W. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102619 · Cited by 4
Further advances in the diagnosis and treatment of Leber’s Hereditary Optic Neuropathy – a review
Tăbăcaru, B., & Stanca, H. T. (2022) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2022.4 · Cited by 4
“Therefore, the macular RGCs axons demonstrated to have mitochondrial clustering and a special sensitivity to energy depletion and reactive oxidative species (ROS) accumulation as it happens in mitochondrial dysfunctions [12,15-24].”
BackgroundJabbar, J., Afroze, B., Ling, N. X. Y., Oakhill, J. S., & Rouiller, I. (2025) · Protein Science · doi:10.1002/pro.70179 · Cited by 3
“…to maintaining mitochondrial DNA copy number, cristae shape, mitophagy, substrate transport, oxidative phosphorylation, and ATP production, apoptosis inhibition, and calcium buffering (Belenguer and Pellegrini 2013; Del Dotto et al. 2018; MacVicar and Langer 2016; Yu-Wai-Man et al. 2016).”
Major, T. C., Arany, E. S., Schon, K. R., Simó, M., Karcagi, V., van den Ameele, J., Yu‐Wai‐Man, P., Chinnery, P. F., Olimpio, C., & Horváth, R. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1292320 · Cited by 3
“This mitochondrial form of LHON (mtLHON) is most commonly associated with one of three mutations, in order of frequency: m.11778G > A (p.Arg340His) in MT-ND4, m.14484T > C (p.Met64Val) in MT-ND6, and m.3460G > A (p.Ala52Thr) in MT-ND1 (1, 7).”
BackgroundSelf-citationEpigenetic Threads of Neurodegeneration: TFAM’s Intricate Role in Mitochondrial Transcription
M, A. B. H., Prabhakaran, P., Logesh, R., Beeraka, N. M., Mathew, B., & Ravanappa, P. K. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273334342250108043032 · Cited by 3
Sun, C., Wu, X., Bai, H.-X., Wang, C., Liu, Z., Yang, C., Lu, Y., & Jiang, P. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1849313 · Cited by 3
Orssaud, C., & Reynier, P. (2025) · Metabolomics · doi:10.1007/s11306-025-02328-x · Cited by 2
“Impairment of complex I activity notably cause increased production of reactive oxygen species and decreased ATP (adenosine triphosphate) production, leading to retinal ganglion cells (RGC) degeneration and apoptosis (Yu-Wai-Man et al., 2016; Newman et al., 2022).”
Valentin, K., Kustermann, M., Schneider, M. R., Aminfar, H., Vollnhofer, K., Wedrich, A., Stapf, C., Bertich, M., Ritter, M., Mendrina, T., et al. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101595 · Cited by 2
Imaging patterns of paediatric CNS mitochondrial disorders
Gaur, P., Alves, C., Yildiz, H., Mankad, K., Sudhakar, S. V., Rahman, S., & Biswas, A. (2025) · Neuroradiology · doi:10.1007/s00234-025-03805-9 · Cited by 2
“Imaging may show isolated optic atrophy or additional features such as cerebellar atrophy, stroke-like lesions [72], basal ganglia and brainstem lesions [74], as well as MS-like lesions [75].”
Late-Onset Leber Hereditary Optic Neuropathy
Battista, M., Carbonelli, M., Brotto, L., Amore, G., Coutinho, C. P., Romagnoli, M., Galzignato, A., Nucci, P., Caporali, L., Cascavilla, M. L., et al. (2026) · Ophthalmology · doi:10.1016/j.ophtha.2026.08.017 · Cited by 2
Self-citationJonak, K. (2020) · Brain Sciences · doi:10.3390/brainsci10090622 · Cited by 2
“Leber’s hereditary optic neuropathy (LHON) is a maternally inherited genetic disease caused by a mutation of mitochondrial DNA (mtDNA) that causes central, bilateral, and progressive visual loss due to optic nerve atrophy, especially in young adult men [1,2].”
BackgroundChermakani, P., Poigaialwar, G., Shanmugam, M., & Sundaresan, P. (2023) · EXCLI journal · doi:10.17179/excli2023-6297 · Cited by 2
Autosomal recessive leber hereditary optic neuropathy in a choroideremia carrier. A case report
Roomets, E., & Mauring, L. (2024) · European Journal of Ophthalmology · doi:10.1177/11206721241254408 · Cited by 2
Şenol, H. B., Soydemir, D., Polat, A. İ., Aydın, A., Kurul, S. H., & Yiş, U. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63902 · Cited by 2
Sergott, R. C., Carelli, V., Newman, N. J., Biousse, V., Yu‐Wai‐Man, P., Vignal‐Clermont, C., Josse, C., Taiel, M., Sahel, J., Barboni, P., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.9.42 · Cited by 2
Self-citationMitochondrial Optic Neuropathies
Carelli, V., Morgia, C. L., & Klopstock, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-05517-2_8 · Cited by 2
Self-citationEfficacy and safety of intravitreal rAAV2-ND4 therapy for Leber’s hereditary optic neuropathy
Jiang, L., Guo, S., Li, B., Xiao, S., Wang, F., & Wei, W. (2025) · Eye · doi:10.1038/s41433-025-03972-2 · Cited by 1
“And m.11778G>A is the most frequently encountered mutation site [1, 2].”
Wu, J., Pan, C., Zhu, R., Huang, X., Lou, X., & Yang, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05774-3 · Cited by 1
Yu‐Wai‐Man, P., Newman, N. J., Carelli, V., Biousse, V., Piérache, A., Montestruc, F., Taiel, M., & Sahel, J. (2026) · British Journal of Ophthalmology · doi:10.1136/bjo-2025-329206 · Cited by 1
Self-citationAn Enhanced Method for Transmitochondrial Cybrid Generation
Weaver, L., & ALEXEYEV, M. F. (2026) · Cells · doi:10.3390/cells15100898 · Cited by 1
Genetic Abnormalities of the Optic Nerve and Color Vision
Toffoli, D., Mathews, M. E., Almeida, T., & Couser, N. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-65414-2.00009-x · Cited by 1
Treatment of Leber Hereditary Optic Neuropathy
Yu‐Wai‐Man, P., & Lam, B. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-98455-1_14 · Cited by 1
Self-citationLeber Mitochondrial Optic Neuropathy in Pediatric Females With Focus on Very Early Onset Cases
Tagliani, S., Malaventura, C., Ceccato, C., Parmeggiani, F., & Suppiej, A. (2023) · Journal of Child Neurology · doi:10.1177/08830738221149962 · Cited by 1
“Diversity between Leber hereditary optic neuropathy phenotypes in pediatric and adult age is explainable by heavier genetic determination, nuclear modifiers, and lower hormonal and environmental influences.(2,4,103,104) Childhood onset is itself a rare condition and it is poorly described in the literature.”
BackgroundInfluentialLeber’s hereditary optic neuropathy: clinical and genetic analysis of Bulgarian patients
Cherninkova, S., Zaharova, B., Kamenarova, K., Mihova, K. Y., Atemin, S., Todorov, T., Haykin, V., Oscar, A. H., Tournev, I., Kaneva, R. P., et al. (2023) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2023.2255073 · Cited by 1
“…in the population in northern European countries ranges from 1:31,000 to 1:50,000 [4,16], and the G11778A mutation is responsible for the onset of the disease in approximately 70–75% of LHON patients from North America and Europe [17,18] and is associated with a more severe clinical course [19].”
BackgroundCastillo, L., Berrozpe‐Villabona, C., García, S. M., Haulani, H., Gómez‐Gutiérrez, C., González‐Martínez, A., Morilla‐Grasa, A., Arias, L., Caminal, J. M., & Casaroli-Marano, R. P. (2023) · Acta Ophthalmologica · doi:10.1111/aos.15811 · Cited by 1
“…related to the retinal changes (either RGC loss or reduced retinal VD), it would be reasonable to expect them mainly in the region beneath the PMB, which is where mitochondrial dysfunction, RGC loss and retinal microvascular changes mainly occur (Borrelli et al., 2018; Yu-Wai-Man et al., 2016).”
BackgroundInfluentialHassan, A. K., Mohsen, M., & Serhan, H. A. A. (2024) · Neuro-Ophthalmology · doi:10.1080/01658107.2024.2360413 · Cited by 1
Chen, J. J.-W., & Brodsky, M. C. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.02.030 · Cited by 1
Autosomal-dominante Optikusatrophie
Reichart, S., Manousaridis, K., & Mennel, S. (2017) · Spektrum der Augenheilkunde · doi:10.1007/s00717-017-0376-3
Veränderungen der Papilla nervi optici im Kindesalter
Tegetmeyer, H. (2018) · Kinder- und Jugendmedizin · doi:10.1055/s-0038-1660970
Veränderungen der Papilla nervi optici im Kindesalter
Tegetmeyer, H. (2019) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-0818-1790
“Eye (Lond) 2011; 25: 596–602 [49] Yu-Wai-Man P, Votruba M, Burté F et al.”
BackgroundInteracting with the environment receiving and interpreting signals
Smith, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819613-7.00001-3
労働・貧困・社会保障(3)福祉国家の胎動と『ベヴァリッジ報告』
唐鎌, 直. (2009) · 労働法律旬報
Genetic disorders affecting the optic nerve
(2022) · Elsevier eBooks · doi:10.1016/b978-0-12-813944-8.00015-9
Karanjia, R., Yu‐Wai‐Man, P., & Newman, N. J. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_45-1
Self-citationParaparesia espástica complicada como fenótipo neurológico em OPA1
Vanni, A. B. C., Pessoni, A. C. P., de Castro, H. B., Carneiro, Z. A., Simão, G. N., & Lourenço, C. M. (2021) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2021.182946
Zou, X.-H., Guo, X.-X., Su, H., Wang, C., Dong, E., Wang, N., Chen, W., & Zhang, Q. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01440-7
Wang, Y., Hu, L., Liu, N.-H., Han, M., Zhou, T., Xing, L., & Jiang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2327478/v1
Martins, S., Santos, M. J., Teixeira, M., Diogo, L. M., Macário, C., Marques, J. P., Fonseca, P., & Grazina, M. M. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.006
Leber hereditary optic neuropathy
Lodhi, T., Sharma, R., & Campos, A. (2023) · Radiopaedia.org · doi:10.53347/rid-172126
Retinal Imaging and Functional Biomarkers of Huntington’s Disease
Saeed, A., & van Wijngaarden, P. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_5
Brain magnetic resonance imaging features in Leber’s hereditary optic neuropathy
Murakhovskaya, Y. K., Sheremet, N. L., Eliseeva, D. D., & Bryukhov, V. V. (2024) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2024140051146
KamaliZonouzi, S., & Micieli, J. A. (2025) · Case Reports in Ophthalmology · doi:10.1159/000545079
Isolated Hereditary Optic Neuropathies
Barboni, P., Balducci, N., & Sadun, A. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_16
Self-citationPacheco, M. C. S. M. A., María Cabarcas, S., & Godin, F. (2022) · Oftalmología clínica y experimental. · doi:10.70313/2718.7446.v15.n1.118
Ophthalmic, Systemic and Genetic Features in Wolfram Syndrome
Cunha, A. M., Estrela‐Silva, S., Barbosa‐Breda, J., Grangeia, A., Carneiro, Â. M., Reis, F. F., & Faria, O. (2025) · Neuro-Ophthalmology · doi:10.1080/01658107.2025.2574723
“8,9 OA is the main ophthalmic manifestation of WFS, encompassing gradual visual acuity loss, color vision defects and cecocentral scotomas on visual field examination.”
Guertin, A., Khanna, R. K., Tardieu, M., François, M., Blasco, H., Bretagne, I. B., Benoist, J., Bigot, A., Tressel, N., Maillot, F., et al. (2025) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2025.101279
“It is well established that the papillomacular bundle is particularly vulnerable to mitochondrial dysfunction [21].”
Chen, B. S. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.114577
Charif, M., Wong, Y. C., Kim, S., Guichet, A., Vignal‐Clermont, C., Zanlonghi, X., Bensaïd, P., Procaccio, V., Bonneau, D., Amati‐Bonneau, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14121759
Palmetshofer, A.-K. (2021) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Leberin perinnöllinen näköhermonsurkastuma - katse kohti hoitoa
Majander, A. S. (2018) · Työväentutkimus Vuosikirja
Vela‐Sebastián, A., & López Gallardo, E. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Clarke, J. E., Yu, A., Kawakibi, T., Le, M., Pack, D., Alves, C., & Acharya, J. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9240
OPA1 Deficiency Impairs NGF Signaling and Drives Sympathetic Neurodegeneration
Ronfini, M., Prando, V., Mauro, V. D., Dokshokova, L., Lazzeri, E., Costantini, I., Alán, L., Rivière, E. A., Incensi, A., Olianti, C., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101460
Self-citationFull moral status and trans-sufferers
Mackett, D. (2026) · SN Social Sciences · doi:10.1007/s43545-026-01391-y
Pathophysiology and gene therapy of the optic neuropathy in Wolfram Syndrome
Jagodzinska, J. (2016) · theses.fr (ABES) · doi:10.70675/d5ad003czb010z456bz8738za3feee533351
“Q6'$:'6%,5'-0G0)'r&-Wai-Man and Chinnery, 2016; Yu-Wai-Man et al., 2016).”
BackgroundInfluentialProof of principle of therapies for dominant optic atrophy type1
Gurram, V. (2020) · theses.fr (ABES) · doi:10.70675/8e22a535zaa4az436bz9cf4z11d1971241f5
Khanna, R. K., Cui, X., Wong, D., Makam, R., Ducloyer, J., de la Barca, J. M. C., Bocca, C., Vignal‐Clermont, C., Blasco, H., Orssaud, C., et al. (2026) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2026.04.006
Self-citation“Triple-hit” pathogenic mechanism of Leber hereditary optic neuropathy
Wang, K., Siqi, L. I., ZHANG, Y., & 管敏鑫 (2026) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2025-0868
Coutinho, C. P., Zanchetta, F., Carbonelli, M., Battista, M., Galzignato, A., Morgia, C. L., Amore, G., Romagnoli, M., Brotto, L., Nucci, P., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.8.8
Self-citationAbu‐Amero, K. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146128
Al-Mutairi, D. A., Al-Mutairi, F. K., Naief, A. A., & Batten, T. F. C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15218336
Metadata
- Authors
- Yu-Wai-Man, P., Votruba, M., Burté, F., La Morgia, C., Barboni, P., & Carelli, V.
- Affiliations
- University Hospital of Wales (GB)
- Wellcome Centre for Mitochondrial Research (GB)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Acta Neuropathologica
- Published
- 2016-09-30
- Volume
- 132
- Issue
- 6
- Pages
- 789-806
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5106504
- OpenAlex
- W2526582958
- Cited by
- 176
- References
- 150
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 17 · 2023: 15 · 2022: 27 · 2021: 22 · 2020: 25 · 2019: 12 · 2018: 15 · 2017: 15 · 2016: 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Medical Research Council (G1002570)
- National Institute for Health Research
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- mitochondrial optic neuropathy, Leber's hereditary optic neuropathy, autosomal dominant optic atrophy, OPA1, mitochondrial DNA mutations, retinal ganglion cell death, papillomacular bundle, melanopsin, neurodegeneration, mitochondrial dysfunction, disease-modifying therapy, genetic engineering, drug delivery
- MeSH terms
- Animals, DNA, Mitochondrial, Humans, Optic Atrophy, Autosomal Dominant, Optic Atrophy, Hereditary, Leber
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.